Come up with a name for your new list and we'll add to it:
PharmSelex raised a round of funding on November 14, 2008. Investors include
The Accelerator Group.
PharmaSelex (fka:GPC-Rx) focuses on the structure prediction of G-protein coupled receptors (GPCRs) to develop new GPCR-targeting drugs with reduced toxicity and enhanced selectivity. GPCRs are cell s…